Rahmati, M.; Zare Ebrahimabad, M.; Langari, A.; Najafi, A.; Taziki, S.; Norouzi, A.; Teimoorian, M.; Khorasani, M.; Mohammadi, S.
Rosuvastatin Intervention in Patients with Chronic Hepatitis B (CHB) Expands CD14+ CD16− Classical Monocytes via Aryl Hydrocarbon Receptor (AHR). Immuno 2024, 4, 159-171.
https://doi.org/10.3390/immuno4020011
AMA Style
Rahmati M, Zare Ebrahimabad M, Langari A, Najafi A, Taziki S, Norouzi A, Teimoorian M, Khorasani M, Mohammadi S.
Rosuvastatin Intervention in Patients with Chronic Hepatitis B (CHB) Expands CD14+ CD16− Classical Monocytes via Aryl Hydrocarbon Receptor (AHR). Immuno. 2024; 4(2):159-171.
https://doi.org/10.3390/immuno4020011
Chicago/Turabian Style
Rahmati, Mina, Mojtaba Zare Ebrahimabad, Alale Langari, Ali Najafi, Shohreh Taziki, Alireza Norouzi, Mehrdad Teimoorian, Milad Khorasani, and Saeed Mohammadi.
2024. "Rosuvastatin Intervention in Patients with Chronic Hepatitis B (CHB) Expands CD14+ CD16− Classical Monocytes via Aryl Hydrocarbon Receptor (AHR)" Immuno 4, no. 2: 159-171.
https://doi.org/10.3390/immuno4020011
APA Style
Rahmati, M., Zare Ebrahimabad, M., Langari, A., Najafi, A., Taziki, S., Norouzi, A., Teimoorian, M., Khorasani, M., & Mohammadi, S.
(2024). Rosuvastatin Intervention in Patients with Chronic Hepatitis B (CHB) Expands CD14+ CD16− Classical Monocytes via Aryl Hydrocarbon Receptor (AHR). Immuno, 4(2), 159-171.
https://doi.org/10.3390/immuno4020011